Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2010, Article ID 206073, 6 pages
http://dx.doi.org/10.1155/2010/206073
Review Article

Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease

Division of Cardiology, Department of Medicine, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada M5B 1W8

Received 1 March 2010; Accepted 6 May 2010

Academic Editor: Rosario Donato

Copyright © 2010 James N. Tsoporis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Donato, G. Sorci, F. Riuzzi et al., “S100B's double life: intracellular regulator and extracellular signal,” Biochimica et Biophysica Acta, vol. 1793, no. 6, pp. 1008–1022, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Engelkamp, B. W. Schafer, M. G. Mattei, P. Erne, and C. W. Heizmann, “Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 14, pp. 6547–6551, 1993. View at Google Scholar · View at Scopus
  3. R. Donato, “S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles,” International Journal of Biochemistry and Cell Biology, vol. 33, no. 7, pp. 637–668, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Becker, V. Gerke, E. Kube, and K. Weber, “S100P, a novel Ca2+-binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties,” European Journal of Biochemistry, vol. 207, no. 2, pp. 541–547, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Emoto, R. Kobayashi, H. Akatsuka, and H. Hidaka, “Purification and characterization of a new member of the S-100 protein family from human placenta,” Biochemical and Biophysical Research Communications, vol. 182, no. 3, pp. 1246–1253, 1992. View at Google Scholar · View at Scopus
  6. D. Kligman and D. R. Marshak, “Purification and characterization of a neurite extension factor from bovine brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 20, pp. 7136–7139, 1985. View at Google Scholar · View at Scopus
  7. J. N. Tsoporis, A. Marks, H. J. Kahn et al., “S100β inhibits α1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes,” Journal of Biological Chemistry, vol. 272, no. 50, pp. 31915–31921, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. J. N. Tsoporis, A. Marks, L. J. Van Eldik, D. O'Hanlon, and T. G. Parker, “Regulation of the S100B gene by α1-adrenergic stimulation in cardiac myocytes,” American Journal of Physiology, vol. 284, no. 1, pp. H193–H203, 2003. View at Google Scholar · View at Scopus
  9. R. Donato, “Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type,” Biochimica et Biophysica Acta, vol. 1450, no. 3, pp. 191–231, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ikura, “Calcium binding and conformational response in EF-hand proteins,” Trends in Biochemical Sciences, vol. 21, no. 1, pp. 14–17, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. R. R. Rustandi, D. M. Baldisseri, and D. J. Weber, “Structure of the negative regulatory domain of p53 bound to S100B(ββ),” Nature Structural Biology, vol. 7, no. 7, pp. 570–574, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Santamaria-Kisiel, A. C. Rintala-Dempsey, and G. S. Shaw, “Calcium-dependent and -independent interactions of the S100 protein family,” Biochemical Journal, vol. 396, no. 2, pp. 201–214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. B. Zimmer and J. G. Dubuisson, “Identification of an S100 target protein: glycogen phosphorylase,” Cell Calcium, vol. 14, no. 4, pp. 323–332, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. C. W. Heizmann and J. A. Cox, “New perspectives on s100 proteins: a multi-functional Ca2+-, Zn2+- and Cu2+ -binding protein family,” BioMetals, vol. 11, no. 4, pp. 383–397, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Donato, “Intracellular and extracellular roles of S100 proteins,” Microscopy Research and Technique, vol. 60, no. 6, pp. 540–551, 2003. View at Google Scholar · View at Scopus
  16. C. Kerkhoff, M. Klempt, and C. Sorg, “Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9),” Biochimica et Biophysica Acta, vol. 1448, no. 2, pp. 200–211, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Newton and N. Hogg, “The human S100 protein MRP-14 is a novel activator of the β2 integrin Mac-1 on neutrophils,” Journal of Immunology, vol. 160, no. 3, pp. 1427–1435, 1998. View at Google Scholar · View at Scopus
  18. A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, “The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses,” Journal of Clinical Investigation, vol. 108, no. 7, pp. 949–955, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Bierhaus, P. M. Humpert, M. Morcos et al., “Understanding RAGE, the receptor for advanced glycation end products,” Journal of Molecular Medicine, vol. 83, no. 11, pp. 876–886, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Leclerc, G. Fritz, S. W. Vetter, and C. W. Heizmann, “Binding of S100 proteins to RAGE: an update,” Biochimica et Biophysica Acta, vol. 1793, no. 6, pp. 993–1007, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. W. Heizmann, G. E. Ackermann, and A. Galichet, “Pathologies involving the S100 proteins and RAGE,” Sub-Cellular Biochemistry, vol. 45, pp. 93–138, 2007. View at Google Scholar · View at Scopus
  22. R. Donato, “RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins,” Current Molecular Medicine, vol. 7, no. 8, pp. 711–724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Leclerc, G. Fritz, M. Weibel, C. W. Heizmann, and A. Galichet, “S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains,” Journal of Biological Chemistry, vol. 282, no. 43, pp. 31317–31331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Ostendorp, E. Leclerc, A. Galichet et al., “Structural and functional insights into RAGE activation by multimeric S100B,” The EMBO Journal, vol. 26, no. 16, pp. 3868–3878, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. P. M. Kilby, L. J. Van Eldik, and G. C. K. Roberts, “Identification of the binding site on S100B protein for the actin capping protein CapZ,” Protein Science, vol. 6, no. 12, pp. 2494–2503, 1997. View at Google Scholar · View at Scopus
  26. J. K. Frizzo, F. Tramontina, E. Bortoli et al., “S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12,” Neurochemical Research, vol. 29, no. 4, pp. 735–740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Kursula, V.-P. Lehto, and A. M. Heape, “S100β inhibits the phosphorylation of the L-MAG cytoplasmic domain by PKA,” Molecular Brain Research, vol. 76, no. 2, pp. 407–410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Baudier and R. D. Cole, “Interactions between the microtubule-associated τ proteins and S100b regulate τ phosphorylation by the Ca2+/calmodulin-dependent protein kinase II,” Journal of Biological Chemistry, vol. 263, no. 12, pp. 5876–5883, 1988. View at Google Scholar · View at Scopus
  29. T. A. Millward, C. W. Heizmann, B. W. Schäfer, and B. A. Hammings, “Calcium regulation of NDR protein kinase mediated by S100 calcium-binding proteins,” The EMBO Journal, vol. 17, no. 20, pp. 5913–5922, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Markowitz, R. R. Rustandi, K. M. Varney et al., “Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53,” Biochemistry, vol. 44, no. 19, pp. 7305–7314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. G. O. Mbele, J. C. Deloulme, B. J. Gentil et al., “The zinc- and calcium-binding S100B interacts and co-localizes with IQGAP1 during dynamic rearrangement of cell membranes,” Journal of Biological Chemistry, vol. 277, no. 51, pp. 49998–50007, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. L. J. Van Eldik and D. B. Zimmer, “Secretion of S-100 from rat C6 glioma cells,” Brain Research, vol. 436, no. 2, pp. 367–370, 1987. View at Google Scholar · View at Scopus
  33. E. R. Peskind, W. S. T. Griffin, K. T. Akama, M. A. Raskind, and L. J. Van Eldik, “Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease,” Neurochemistry International, vol. 39, no. 5-6, pp. 409–413, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. L. V. C. Portela, J. C. T. Brenol, R. Walz et al., “Serum S100B levels in patients with lupus erythematosus: preliminary observation,” Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 1, pp. 164–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Hu and L. J. Van Eldik, “S100β induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway,” Biochimica et Biophysica Acta, vol. 1313, no. 3, pp. 239–245, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. H. J. Huttunen, J. Kuja-Panula, G. Sorci, A. L. Agneletti, R. Donato, and H. Rauvala, “Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation,” Journal of Biological Chemistry, vol. 275, no. 51, pp. 40096–40105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. L. J. Van Eldik and W. S. T. Griffin, “S100β expressiion in Alzheimer's disease: relation to neuropathology in brain regions,” Biochimica et Biophysica Acta, vol. 1223, no. 3, pp. 398–403, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. W. S. T. Griffin, J. G. Sheng, J. E. Mckenzie et al., “Life-long overexpression of S100β in Down's syndrome: implications for Alzheimer pathogenesis,” Neurobiology of Aging, vol. 19, no. 5, pp. 401–405, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. M. C. Schaub and C. W. Heizmann, “Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies,” Biochemical and Biophysical Research Communications, vol. 369, no. 1, pp. 247–264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. R. E. Anderson, L.-O. Hansson, and J. Vaage, “Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery,” Annals of Thoracic Surgery, vol. 67, no. 6, pp. 1721–1725, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. G. S. Mazzini, D. V. Schaf, E. R. Vinadé et al., “Increased S100B serum levels in dilated cardiomyopathy patients,” Journal of Cardiac Failure, vol. 13, no. 10, pp. 850–854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. H. E. Morgan and K. M. Baker, “Cardiac hypertrophy. Mechanical, neural, and endocrine dependence,” Circulation, vol. 83, no. 1, pp. 13–25, 1991. View at Google Scholar · View at Scopus
  43. K. R. Chien, H. Zhu, K. U. Knowlton et al., “Transcriptional regulation during cardiac growth and development,” Annual Review of Physiology, vol. 55, pp. 77–95, 1993. View at Google Scholar · View at Scopus
  44. A. M. Katz, “Is heart failure an abnormality of myocardial cell growth?” Cardiology, vol. 77, no. 5, pp. 346–356, 1990. View at Google Scholar · View at Scopus
  45. T. G. Parker, “Molecular biology of cardiac growth and hypertrophy,” Herz, vol. 18, no. 4, pp. 245–255, 1993. View at Google Scholar · View at Scopus
  46. T. G. Parker and M. D. Schneider, “Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype,” Annual Review of Physiology, vol. 53, pp. 179–200, 1991. View at Google Scholar · View at Scopus
  47. J. N. Tsoporis, A. Marks, H. J. Kahn et al., “Inhibition of norepinephrine-induced cardiac hypertrophy in S100β transgenic mice,” Journal of Clinical Investigation, vol. 102, no. 8, pp. 1609–1616, 1998. View at Google Scholar · View at Scopus
  48. J. N. Tsoporis, A. Marks, A. Haddad, F. Dawood, P. P. Liu, and T. G. Parker, “S100B expression modulates left ventricular remodeling after myocardial infarction in mice,” Circulation, vol. 111, no. 5, pp. 598–606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. J. N. Tsoporis, C. B. Overgaard, S. Izhar, and T. G. Parker, “S100B modulates the hemodynamic response to norepinephrine stimulation,” American Journal of Hypertension, vol. 22, no. 10, pp. 1048–1053, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. K.-I. Kariya, L. R. Karns, and P. C. Simpson, “Expression of a constitutively activated mutant of the β-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the β-myosin heavy chain isogene,” Journal of Biological Chemistry, vol. 266, no. 16, pp. 10023–10026, 1991. View at Google Scholar · View at Scopus
  51. E. Morkin, “Control of cardiac myosin heavy chain gene expression,” Microscopy Research and Technique, vol. 50, no. 6, pp. 522–531, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Haase, T. Podzuweit, G. Lutsch et al., “Signaling from β-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK,” The FASEB Journal, vol. 13, no. 15, pp. 2161–2172, 1999. View at Google Scholar · View at Scopus
  53. B. J. Gentil, C. Delphin, G. O. Mbele et al., “The giant protein AHNAK is a specific target for the calcium-and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B,” Journal of Biological Chemistry, vol. 276, no. 26, pp. 23253–23261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Sigurdsson, P. Held, and K. Swedberg, “Short- and long-term neurohormonal activation following acute myocardial infarction,” American Heart Journal, vol. 126, no. 5, pp. 1068–1076, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. H. M. Razavi, J. A. Hamilton, and Q. Feng, “Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure,” Pharmacology and Therapeutics, vol. 106, no. 2, pp. 147–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. J. N. Tsoporis, S. Izhar, and T. G. Parker, “Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-α,” Journal of Biological Chemistry, vol. 283, no. 44, pp. 30174–30183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J. N. Tsoporis, A. Marks, A. Haddad, D. O'Hanlon, S. Jolly, and T. G. Parker, “S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes,” Experimental Cell Research, vol. 303, no. 2, pp. 471–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. J. N. Tsoporis, S. Izhar, H. Leong-Poi, J.-F. Desjardins, H. J. Huttunen, and T. G. Parker, “S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction,” Circulation Research, vol. 106, no. 1, pp. 93–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Iuvone, G. Esposito, D. De Filippis et al., “Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro,” Journal of Molecular Medicine, vol. 85, no. 12, pp. 1379–1392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Delphin, M. Ronjat, J. C. Deloulme et al., “Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53,” Journal of Biological Chemistry, vol. 274, no. 15, pp. 10539–10544, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. D. S. Gonçalves, G. Lenz, J. Karl, C. A. Gonçalves, and R. Rodnight, “Extracellular S100B protein modulates ERK in astrocyte cultures,” NeuroReport, vol. 11, no. 4, pp. 807–809, 2000. View at Google Scholar · View at Scopus
  62. D. B. Zimmer, E. H. Cornwall, A. Landar, and W. Song, “The S100 protein family: history, function, and expression,” Brain Research Bulletin, vol. 37, no. 4, pp. 417–429, 1995. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Remppis, T. Greten, B. W. Schäfer et al., “Altered expression of the Ca2+-binding protein S100A1 in human cardiomyopathy,” Biochimica et Biophysica Acta, vol. 1313, no. 3, pp. 253–257, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. J. N. Tsoporis, A. Marks, D. B. Zimmer, C. McMahon, and T. G. Parker, “The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart,” Molecular and Cellular Biochemistry, vol. 242, no. 1-2, pp. 27–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. J.-F. Desjardins, A. Pourdjabbar, A. Quan et al., “Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction,” American Journal of Physiology, vol. 296, no. 5, pp. H1457–H1465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. P. Most, H. Seifert, E. Gao et al., “Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction,” Circulation, vol. 114, no. 12, pp. 1258–1268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Most, M. Boerries, C. Eicher et al., “Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2),” Journal of Biological Chemistry, vol. 278, no. 48, pp. 48404–48412, 2003. View at Publisher · View at Google Scholar · View at Scopus